Pfizer (PFE) Announces Positive Top-Line Data from BeneFIX Coagulation Factor IX Phase 3 in Hemophilia B
Tweet Send to a Friend
Pfizer (NYSE: PFE) announced the positive results of a Phase 3 study comparing a prophylaxis regimen of BeneFIX Coagulation Factor ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
